UCSF Helen Diller Family Comprehensive Cancer Center

Photo of Anthony L. DeFranco, PhD  Anthony L. DeFranco, PhD

Professor, Department of Microbiology and Immunology, UCSF

Member, UCSF Biomedical Sciences Graduate Program (BMS)
Member, UCSF Herbert W. Boyer Program in Biological Sciences (PIBS)
Member, UCSF Immunology Graduate Program

Contact

.(JavaScript must be enabled to view this email address)
(415) 476-5488 (voice)
(415) 476-6185 (fax) (fax)

Box 0552, UCSF; San Francisco, CA 94143-0552

Education

Harvard College, Cambridge MA, A.B., 1975, Biochemical & Molecular Biology
University of California, Berkeley, CA, Ph.D., 1979, Biochemistry
National Institutes of Health, Bethesda MD, Postdoctoral, 1979-83, Immunology

Professional Experience

  • 1972-1975
    Undergraduate research, laboratory of Dr. Jack Strominger. HLA antigens.
  • 1976-1979
    Graduate research, laboratory of Dr. Daniel E. Koshland, Jr. Bacterial chemotaxis.
  • 1979-1983
    Postdoctoral research, laboratory of Dr. William E. Paul. B cell activation.
  • 1983-1988
    Assistant Professor, UCSF, Department of Microbiology & Immunology,
  • 1988-1994
    Associate Professor, UCSF, Department of Microbiology & Immunology
  • 1989-1990
    Sabbatical with David Baltimore, Whitehead Insititute, MIT, Cambridge, MA
  • 1994-present
    Professor, UCSF, Department of Microbiology & Immunology
  • 1997-1998
    Sabbatical with Suzanne Cory, Walter and Eliza Hall Institute, Melbourne, Australia
  • 1998-2004
    Scientific Advisory Board, Abgenix, Inc. Fremont, CA
  • 1999-2009
    Chairman, Department of Microbiology & Immunology, UCSF

Honors & Awards

  • 1974
    Dreyfuss Foundation Fellow
  • 1975
    Phi Beta Kappa, Harvard University
  • 1975-78
    NSF Predoctoral Fellow
  • 1979-82
    Helen Hay Whitney Postdoctoral Fellow; 2nd Rose Lieberman Lecturer, NIH 10/93
  • 1994
    NIAID Merit Award
  • 1997-98
    NIH Fogarty Senior International Award

Selected Publications

  • Chan, V.W.F., F. Meng, P. Soriano, A.L. DeFranco, and C.A. Lowell (1997). Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation. Immunity 7: 69-81.
  • Crowley, M.T., P.S. Costello, M. Turner, F. Meng, C. Lowell, V.L.J. Tybulewicz, and A.L. DeFranco (1997). A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages. J. Exp. Med. 186: 1027-1039. PMC2199061
  • Chan, V.W.F., C.A.Lowell, and A.L. DeFranco (1998). Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8: 545-553.
  • Fitzer-Attas, C.J., M. Lowry, M.T. Crowley, A.J. Finn, F. Meng, A.L. DeFranco, and C.A. Lowell (2000). Fcγ receptor-mediated phagocytosis in macrophages lacking the Src-family tyrosine kinases Hck, Fgr, and Lyn. J. Exp. Med. 191: 669-682. PMC2195832
  • Yu, C.C.K., T.S.B. Yen, C.A. Lowell, and A.L. DeFranco (2001). Lupus-like kidney disease in mice deficient in Src-family protein tyrosine kinases Lyn and Fyn. Curr. Biol. 11:34-38.
  • Richards, J.D., S. Dave, C.-H. G. Chou, A.A. Mamchak and A.L. DeFranco (2001). Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol.166:3855-64.
  • Gupta, N. and A.L. DeFranco (2003). Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B lymphocyte activation. Molec. Biol. Cell 14: 432-444. PMC149983
  • Nishiya, T. and A.L. DeFranco (2004). Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J. Biol. Chem. 279:19008-17.
  • Tian, M.X., G. Gonzalez, B. Scheer, and A.L. DeFranco (2005). Bcl10 can promote survival of antigen-stimulated B lymphocytes. Blood 106: 2105-12. PMC1895143
  • Nishiya, T. Kajita, E., Miwa, S. and A.L. DeFranco (2005). TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 280: 37107-17.
  • Gupta, N., B. Wollscheid, J.D. Watts, B. Scheer, R. Aebersold, and A.L. DeFranco (2006). Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nature Immunol. 7: 625-633.
  • Hou, B., B. Reizis, and A.L. DeFranco (2008). Toll-like receptors activate innate and adaptive immunity using dendritic cell-dependent and -independent mechanisms. Immunity 29: 272-82. PMC2847796
  • Mamchak, A.A., B.M. Sullivan, B. Hou, L.M. Lee, J.K. Gilden, M.F. Krummel, R.M. Locksley, and A.L. DeFranco (2008). Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells. J. Immunol. 181: 5374-5385. PMC2657555
  • Gross, A.J., J.R. Lyandres, A.K. Panigrahi, E..T.L. Prak, and A.L. DeFranco (2009). Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B Cell tolerance. J. Immunol. 182: 5382-92. PMC2840041
  • Mamchak, A.A., C.B.F. Thien, S.A. Dagger, J. Lyandres, S. Jiang, W.Y. Langdon, and A.L. DeFranco (2010). Unaltered negative selection and regulatory T cell development of self-reactive thymocytes in TCR transgenic Fyn-deficient mice. Eur. J. Immunol. 40: 539-547. PMC submission in process (NIHMS179030)
  • Scapini, P., Y. Hu, C.L. Chu, T.S. Migone, A.L. DeFranco, M.A. Cassatella, and C.A. Lowell (2010). Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207:1757-73.

Updated: November 24, 2010